Nanovesicles Loaded with a TGF-β Receptor 1 Inhibitor Overcome Immune Resistance to Potentiate Cancer Immunotherapy

Scientists identified that inhibition of transforming growth factor-β (TGF-β) receptor 1 could relieve tumor fibrosis, thus facilitating the recruitment of tumor-infiltrating T lymphocytes.